"The Investors's Chief Problem--and even his worst enemy--is likely to be himself"
---Benjamin Graham
Recent NDRA News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/16/2024 09:28:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 09:09:43 PM
- ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements • Business Wire • 08/28/2024 08:17:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:06:08 PM
- ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update • Business Wire • 08/22/2024 08:14:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:10:30 PM
- ENDRA Life Sciences Announces Reverse Stock Split • Business Wire • 08/16/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2024 09:00:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:06:44 PM
- ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024 • Business Wire • 08/13/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 01:24:59 PM
- ENDRA Life Sciences Announces Leadership Changes • Business Wire • 08/13/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 12:02:42 PM
- ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14 • Business Wire • 08/07/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 08:16:45 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 06/14/2024 08:01:26 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 06/14/2024 12:00:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 12:00:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/05/2024 04:15:12 AM
- ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering • Business Wire • 06/04/2024 01:21:00 PM
FEATURED CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • Oct 8, 2024 8:00 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM